“Through the use of automation and advanced software, pharmacists can focus more of their time on higher value clinical work and patient interactions to help improve medication adherence, medication safety and patient outcomes,” the June 6 statement said.
Three things to know about the deal:
1. Parata specializes in “medication adherence packaging, high-speed robotic dispensing technologies and pharmacy workflow solutions,” according to the press release.
2. A private equity firm in the healthcare sector, Frazier Healthcare Partners, is the current owner of Parata.
3. The companies expect the transaction to finalize at the end of the first half of BD’s fiscal year 2023.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
